Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

OBJECTIVES: This project was undertaken to assess the risk of malignancy in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors (TNFi) in clinical practice, as recorded in prospective, observational studies. METHODS: The authors undertook comprehensive searches of MEDLI...

Full description

Bibliographic Details
Main Authors:	Mariette, X, Matucci-Cerinic, M, Pavelka, K, Taylor, P, van Vollenhoven, R, Heatley, R, Walsh, C, Lawson, R, Reynolds, A, Emery, P
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Tumour necrosis factor.
by: Van Der Merwe, P
Published: (1988)

Malignant pituitary tumours.
by: Kaltsas, G, et al.
Published: (1998)

Structure of tumour necrosis factor.
by: Jones, E, et al.
Published: (1989)

Avascular tumour dynamics and necrosis
by: Please, C, et al.
Published: (1999)

Concerning the Origin of Malignant Tumours
by: Gull, K
Published: (2010)

Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data
by: Hawley, S, et al.
Published: (2018)

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis.
by: Catherine, S, et al.
Published: (2005)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

The three-dimensional structure of tumour necrosis factor.
by: Jones, E, et al.
Published: (1990)

Tumour dynamics and necrosis: surface tension and stability.
by: Landman, K, et al.
Published: (2001)

Malignant Presentation of Benign Tumour of the Rectum
by: Sanjeev Sandrasecra, et al.
Published: (2020)

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
by: Watts, L, et al.
Published: (2018)

Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis.
by: Williams, R
Published: (2008)

The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
by: Kaltsas, G, et al.
Published: (2001)

Wilms tumour and paternal occupation: an analysis of data from the National Registry of Childhood Tumours.
by: Fear, N, et al.
Published: (2009)

Wilms tumour and paternal occupation: an analysis of data from the National Registry of Childhood Tumours
by: Fear, N, et al.
Published: (2009)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
by: Mukhtyar, C, et al.
Published: (2005)

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Antagonism of tumour necrosis factor alpha in refractory asthma.
by: Berry, M, et al.
Published: (2008)

The structure of tumour necrosis factor--implications for biological function.
by: Jones, E, et al.
Published: (1990)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
by: Culpan, D, et al.
Published: (2003)

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
by: Taylor, P, et al.
Published: (2004)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
by: Williams, R, et al.
Published: (2000)

The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
by: Sawyer, E, et al.
Published: (2002)

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort
by: Yahya, Fariz, et al.
Published: (2017)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
by: Cullen, SN, et al.
Published: (2003)

Breast necrosis: a rare case of neglected phyllodes tumour
by: Ho Hui Lian, et al.
Published: (2019)

Stimulators of tumour necrosis factor production released by damaged erythrocytes.
by: Bate, C, et al.
Published: (1994)

The effects of pressure on chondrocyte tumour necrosis factor receptor expression.
by: Westacott, C, et al.
Published: (2002)

The tumour necrosis factor receptor family: life or death choices.
by: Jones, E
Published: (2000)

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
by: Sawyer, E, et al.
Published: (2003)

Nasal Chondromesenchymal Hamartoma masquerading as malignant paediatric tumour
by: Tan, Sui Teng, et al.
Published: (2019)

Intratumoural lymphatics in benign and malignant soft tissue tumours.
by: Mahendra, G, et al.
Published: (2008)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation.
by: Marsh, H, et al.
Published: (2003)

Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.
by: Neve, R, et al.
Published: (1996)

Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.
by: Travis, S, et al.
Published: (2001)

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
by: Furst, D, et al.
Published: (2000)

HDAC inhibitor-based therapies and haematological malignancy.
by: Stimson, L, et al.
Published: (2009)

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
by: Zheng, R, et al.
Published: (1992)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)